SCHEMBL1778613

SCHEMBL1778613

CCOC(=O)n1nc(NC(=O)c2ccc(N3CCN(C)CC3)cc2NC(=O)c2ccco2)c2cc(C(=O)NC(C)(C)c3ccccc3F)sc21

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BTK Q06187 3/20 0.40
INSR P06213 10/20 0.38
ALK Q9UM73 10/20 0.38
AURKA O14965 2/20 0.37
ABL1 P00519 1/20 0.37
BCR P11274 1/20 0.37
KIT P10721 1/20 0.37
FLT3 P36888 1/20 0.37
IGF1R P08069 5/20 0.36
CSF1R P07333 1/20 0.35
KISS1R Q969F8 1/20 0.35
AURKB Q96GD4 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1779991 0.92 AURKA (0.45) BTKINSRALKAURKAABL1
SCHEMBL1779824 0.89 RAF1 (0.38) BTKINSRALKAURKAABL1
SCHEMBL1778410 0.89 ALDH1A1 (0.40) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL1779011 0.89 IGF1R (0.43) BTKINSRALKAURKAABL1
SCHEMBL1777980 0.88 AURKA (0.40) BTKINSRALKAURKAABL1
SCHEMBL1781437 0.88 BTK (0.45) BTKINSRALKAURKAIGF1R
SCHEMBL1778750 0.87 BTK (0.45) BTKINSRALKAURKAKIT
SCHEMBL1778668 0.87 PDE7A (0.41) BTKINSRALKAURKAABL1
SCHEMBL1779183 0.87 ALK (0.42) BTKINSRALKAURKAABL1
SCHEMBL1780225 0.85 SIRT6 (0.39) BTKINSRALKAURKAABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904503-B1 1H-THIENO[2,3-C]-PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2013-11-06 EP disclosed
US-7943654-B2 1H-thieno[2,3-c]pyrazole compounds useful as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-05-17 US disclosed
US-20090149457-A1 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149457-A1 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors CCNH, PDK1, MAP3K5 BTK 940/4885INSR 1010/4885ALK 423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.